login
login

Europe Daily Bulletin No. 12693

8 April 2021
Contents Publication in full By article 1 / 20
EU RESPONSE TO COVID-19
HEALTH: European Medicines Agency confirms adverse effects of AstraZeneca vaccine without putting its effectiveness in question
Brussels, 07/04/2021 (Agence Europe)

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) confirmed on Wednesday 7 April that the cases of thrombosis, accompanied by a low level of blood platelets, are indeed side effects of the Covid-19 vaccine produced by the Anglo-Swedish firm AstraZeneca.

This conclusion—which does not call into question the benefit-risk ratio of the product—had not been completely excluded in the previous analysis conducted by the EMA (see EUROPE B12681A2).

Contents

EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
SECTORAL POLICIES
NEWS BRIEFS